Psychometric properties and comparison of four health utility approaches among myopia patients in China

Dou, Lei; Xu, Yanjiao; Chen, Gang; Li, Shunping

doi:10.1186/s12955-023-02150-w

Health and Quality of Life Outcomes

Table 5 Efficiency of the four utility approaches to detect clinically relevant differences

From: Psychometric properties and comparison of four health utility approaches among myopia patients in China

Groups	TTO		SG		AQoL-7D		VFQ-UI
Groups	Mean (SD)	ES	Mean (SD)	ES	Mean (SD)	ES	Mean (SD)	ES
NEI-VFQ-25 Total
< 85	0.95 (0.06)	0.042	0.95 (0.09)	0.064	0.76 (0.11)	0.850	0.77 (0.10)	1.806
≥ 85	0.95 (0.06)		0.95 (0.11)		0.84 (0.10)		0.90 (0.03)
RE	0.002		0.006		1		4.496
AUC	0.531		0.509		0.734*		0.924*
NEI-VFQ-25 GH
< 75	0.94 (0.06)	0.217	0.94 (0.10)	0.084	0.75 (0.11)	0.706	0.81 (0.11)	0.376
≥ 75	0.95 (0.06)		0.95 (0.10)		0.82 (0.10)		0.84 (0.09)
RE	0.088		0.014		1		0.254
AUC	0.564*		0.531		0.689*		0.605*
NEI-VFQ-25 GV
< 60	0.94 (0.09)	0.238	0.95 (0.09)	0.021	0.74 (0.11)	0.696	0.77 (0.10)	0.784
≥ 60	0.95 (0.05)		0.95 (0.11)		0.81 (0.11)		0.85 (0.09)
RE	0.062		0.001		1		1.267
AUC	0.534		0.517		0.701*		0.735*
NEI-VFQ-25 OP
< 87	0.95 (0.06)	0.025	0.95 (0.10)	0.039	0.77 (0.11)	0.473	0.80 (0.11)	0.587
≥ 87	0.95 (0.06)		0.95 (0.10)		0.82 (0.10)		0.85 (0.09)
RE	0.003		0.007		1		1.281
AUC	0.493		0.495		0.632*		0.654*
NEI-VFQ-25 NA
< 91	0.94 (0.07)	0.213	0.96 (0.08)	0.117	0.75 (0.11)	0.649	0.73 (0.10)	2.022
≥ 91	0.95 (0.05)		0.95 (0.11)		0.82 (0.11)		0.88 (0.05)
RE	0.085		0.032		1		6.379
AUC	0.565*		0.496		0.681*		0.894*
NEI-VFQ-25 DA
< 83	0.95 (0.06)	0.065	0.95 (0.09)	0.046	0.76 (0.10)	0.800	0.77 (0.11)	1.478
≥ 83	0.95 (0.06)		0.95 (0.11)		0.84 (0.10)		0.89 (0.05)
RE	0.007		0.003		1		3.191
AUC	0.529		0.511		0.722*		0.847*
NEI-VFQ-25 SF
< 100	0.94 (0.06)	0.160	0.95 (0.09)	0.007	0.76 (0.10)	0.747	0.76 (0.11)	1.580
≥ 100	0.95 (0.06)		0.95 (0.10)		0.83 (0.10)		0.89 (0.05)
RE	0.046		0.000		1		3.753
AUC	0.576*		0.517		0.710*		0.859*
NEI-VFQ-25 MH
< 81	0.94 (0.06)	0.174	0.95 (0.08)	0.006	0.75 (0.10)	0.928	0.76 (0.11)	1.495
≥ 81	0.95 (0.06)		0.95 (0.11)		0.84 (0.10)		0.88 (0.06)
RE	0.035		0.000		1		2.054
AUC	0.581*		0.557*		0.748*		0.851*
NEI-VFQ-25 RD
< 87	0.95 (0.06)	0.006	0.96 (0.08)	0.172	0.77 (0.11)	0.484	0.78 (0.11)	1.196
≥ 87	0.95 (0.06)		0.94 (0.11)		0.83 (0.10)		0.88 (0.05)
RE	0.000		0.130		1		5.854
AUC	0.501		0.475		0.642*		0.794*
NEI-VFQ-25 Dependency
< 91	0.95 (0.06)	0.098	0.95 (0.10)	0.047	0.75 (0.11)	0.782	0.77 (0.11)	1.429
≥ 91	0.95 (0.06)		0.95 (0.10)		0.83 (0.10)		0.88 (0.05)
RE	0.016		0.004		1		2.662
AUC	0.541		0.551		0.716*		0.825*
NEI-VFQ-25 Driving
< 75	0.95 (0.06)	0.103	0.95 (0.10)	0.009	0.78 (0.12)	0.391	0.80 (0.11)	0.694
≥ 75	0.95 (0.06)		0.95 (0.09)		0.82 (0.10)		0.87 (0.07)
RE	0.070		0.001		1		3.077
AUC	0.543		0.507		0.608*		0.692*
NEI-VFQ-25 CV
< 100	0.94 (0.06)	0.129	0.96 (0.09)	0.094	0.76 (0.11)	0.464	0.73 (0.11)	1.577
≥ 100	0.95 (0.06)		0.95 (0.10)		0.81 (0.11)		0.86 (0.07)
RE	0.077		0.041		1		7.561
AUC	0.540		0.486		0.635*		0.839*
NEI-VFQ-25 PV
< 100	0.94 (0.06)	0.167	0.95 (0.09)	0.028	0.77 (0.11)	0.627	0.77 (0.11)	1.356
≥ 100	0.95 (0.05)		0.95 (0.10)		0.83 (0.10)		0.89 (0.05)
RE	0.071		0.002		1		4.252
AUC	0.562*		0.519		0.674*		0.812*

For the RE analysis, reference is AQoL-7D
RE Relative efficiency, AUC Area under the ROC curve, ES Effect size
GH General health, GV General vision, OP Ocular pain, NA Near activities, DA Distance activities, SF Social function, MH Mental health, RD Role difficulties, CV Color vision, PV Peripheral vision
^* P < 0.001

Back to article page

ISSN: 1477-7525

Contact us

Submission enquiries: journalsubmissions@springernature.com